Yu Cao
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 20
Publications (10 Years): 20
Publications
- Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao
- Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao
- Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu, Yu Cao
- Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao
- Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu, Yu Cao
- Zhao-Xin Wu, Chen-Jing Wang, Ping Shi, Yan-Ping Liu, Ting Li, Fei-Fei Sun, Yao Fu, Xiao-Meng Gao, Ya-Ping Ma, Yu Cao
- Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao
- Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu, Yu Cao
- Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao
- Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu, Yu Cao
- Feifei Sun, Chenjing Wang, Yi Xu, Pingping Lin, Yaozhong Cao, Jiahui Zhang, Xin Li, Xin Jiang, Yao Fu, Yu CaoRandomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
- Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao
- Feifei Sun, Chenjing Wang, Yi Xu, Pingping Lin, Yaozhong Cao, Jiahui Zhang, Xin Li, Xin Jiang, Yao Fu, Yu CaoRandomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
- Yan-Ping Liu, Ming-Hui Hu, Ping-Ping Lin, Ting Li, Shu-Qin Liu, Yu-Ya Wang, Shao-Rong Li, Xiang-Kun Li, Chen-Jing Wang, Yu Cao
- Chen-Jing Wang, Ting Li, Ping-Ping Lin, Ye Tao, Xin Jiang, Xin Li, Qing Wen, Yu Cao
- Ping Shi, Xin Liu, Ting Li, Fei-Fei Sun, Yan-Ping Liu, Shu-Qin Liu, Xiao-Meng Gao, Ya-Ping Ma, Yao Fu, Yu Cao
- Xin Liu, Suqin Wu, Jian Sun, Suiqin Ni, Laichun Lu, Wei Hu, Hua Wei, Yanqin Zou, Ting Li, Jintong Li, Bugela Mijiti, PingFei Fang, Li-Mei Zhao, Huan Zhou, Xiaoming Xing, Haitao Niu, Yu Cao
- Xin Li, Chenjing Wang, Ting Li, Yanping Liu, Shuqin Liu, Ye Tao, Yaping Ma, Xiaomeng Gao, Yu Cao
- Chen-Jing Wang, Xin Li, Ping Shi, Hai-Yan Ding, Yan-Ping Liu, Ting Li, Ping-Ping Lin, Yun-Shan Wang, Guo-Qing Zhang, Yu Cao